Navigation Links
Federal Judge Fines Boehringer Ingelheim More Than $931K Due To Missing Evidence in Pradaxa Lawsuits Disturbs Wright & Schulte LLC
Date:12/12/2013

Columbus, OH (PRWEB) December 12, 2013

The Pradaxa lawyers at Wright & Schulte LLC are disturbed by a recent court filing that indicates Boehringer Ingelheim had failed to preserve a large amount of evidence relevant to Pradaxa lawsuits now pending in a multidistrict litigation underway in Illinois federal court. According to court documents, the federal judge overseeing the federal Pradaxa litigation sanctioned Boehringer Ingelheim and fined the drug maker more than $931,000 for failing to preserve “countless” documents sought by plaintiffs who have filed claims against the company. In a 51-page decision dated December 9th, Judge David Herndon of the U.S. District Court, Southern District of West Virginia, slammed Boehringer Ingelheim for “gross inadequacy,” and stated the company “made misrepresentations” and acted “in bad faith” by failing to ensure the documents were preserved. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

The documents sought by plaintiffs related to Pradaxa’s development, as well Boehringer Ingelheim’s plans for marketing the blood thinner, according to the ruling. Among other things, Judge Herndon found that company officials “failed to ensure the auto-delete feature of their employee cellphones, company owned and personal, was disengaged for the purpose of preserving text messages.” This resulted in the destruction of “countless records,” he wrote.

According to Wright & Schulte LLC the details laid out by Judge Herndon in his decision are disturbing, and would certainly appear to justify such a large sanction. The firm hopes this will serve as a warning to defendants in other large litigations to take adequate steps to preserve evidence relevant to plaintiffs’ claims.

[ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP QuarterWatch, October 17, 2013]

Through court documents, Wright & Schulte LLC has also learned that at least
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New federal disclosure law may have little impact on drugs prescribed
2. Study examines federal government payments to separate managed care programs for same patients
3. Federally funded clinics for low-income patients as effective as private practices
4. American College of Physicians awarded 3-year federal grant to increase adult immunization rates
5. Federal government renews contract for collecting and maintaining national stem cell transplantation database
6. ACP and NACHC collaborate to help federally-qualified heath centers improve care
7. St. Michaels Dr. Sean B. Rourke receives federal funds for iHIV/AIDS research
8. New poll shows US public supports continued investment in Federal Nutrition Assistance Program
9. Kessler awarded $2 million federal grant for Northern NJ Traumatic Brain Injury System
10. Fake Drugs Entering the U.S.: Lawyers at Console & Hollawell Highlight Federal Warnings About Counterfeit Medications
11. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... New York, NY (PRWEB) , ... September 01, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – today announced its annual Light it Red for Lymphoma awareness ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Philanthropic giving ... awareness of societal issues and needs. Money for Good 2015, released today by Camber ... it. There’s an annual potential to mobilize up to $22B in new philanthropic giving ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... of the American Society for Dermatologic Surgery, according to a new survey that ... Consumer Survey on Cosmetic Dermatologic Procedures – which reflects views on cosmetic medical ...
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia ... Machine,” is still strongly maintaining her firm’s success in the hair care and ... her upcoming city-to-city tour, Ellis will be providing “Look and learn” live demonstrations, ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Jerry Segal Classic ... ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over the past ... than $13.5 million for programs and services designed to support patients and their families ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... for Fluocinonide Cream 0.1%, a generic version of,VANOS(R) Cream ... to file an,ANDA with a Paragraph IV certification against ... (steroid,hormone) approved to relieve the inflammation and itching caused ...
... rosiglitazone showed 59.5% reduced risk of retina damage , , ... may slow the progression of eye disease in diabetes ... Eye Institute at the University of California, Los Angeles. ... the drug were less likely to develop proliferative diabetic ...
... say it will be several years before there,s widespread ... sophisticated new imaging device could one day help doctors ... earlier and more accurately, researchers report. , If left ... sudden or acute glaucoma attack, which can result in ...
... Results from five pivotal phase 3 studies of ... Association (ADA) 68th Scientific Sessions by Takeda Global ... has been shown to be a highly selective ... investigation as an oral treatment for type 2 ...
... June 9 Today, Earvin "Magic",Johnson ( ... (NYSE: ABT ) and the Magic ... as part of the,"I Stand With Magic ... Black HIV/AIDS,",directed by Academy Award-nominated director Spike ...
... U.S.,Fund for UNICEF and global pharmaceutical company, Merck & ... of M-M-R(R) II,(measles, mumps and rubella virus vaccine, live, ... Moldova, in response to an,ongoing serious mumps outbreak in ... against three diseases, measles,mumps, and rubella, and will be ...
Cached Medicine News:Health News:Perrigo Confirms Filing for Generic Version of VANOS(R) 2Health News:Diabetes Drug May Slow Eye Disease 2Health News:New Imaging Tool Can Spot Glaucoma Risk 2Health News:New Imaging Tool Can Spot Glaucoma Risk 3Health News:Phase 3 results for alogliptin 2Health News:Phase 3 results for alogliptin 3Health News:Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign 2Health News:Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign 3Health News:Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign 4Health News:UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic 2Health News:UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic 3
(Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
(Date:9/1/2015)... , Sept. 1, 2015  Dr. Cindy ... Labs , the cannabis testing subsidiary of DigiPath, Inc. ... Group about the lack of consistency in today,s ... online resource for medical cannabis information, she explained that ... because their lack of uniform requirements makes standardization impossible. ...
(Date:9/1/2015)... 1, 2015   Alpha Imaging LLC , a leading distributor ... announced today that they have been awarded exclusive rights to ... in Michigan.   The new territory supplements Alpha Imaging,s existing Shimadzu sales ... Ohio , Indiana , ... , West Virginia , Delaware ...
Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Alpha Imaging Expands Shimadzu Territory 2
... Medical Systems (NYSE: VAR ) today announced that ... N.A. to repurchase $250 million of its common stock under ... revolving credit facility with Bank of America, N.A. to increase ... Under the accelerated repurchase agreement, Varian will pay $250 ...
... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced ... trial evaluating the safety and pharmacokinetics of dabigatran ... valves.(1) The 12-week study will compare three doses ... 300mg bid) to warfarin in patients with both ...
Cached Medicine Technology:Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 2Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 7
... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: